Scott Jeffers
Director Técnico/Científico/I+D en GENSIGHT BIOLOGICS S.A. .
Cargos activos de Scott Jeffers
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Director Técnico/Científico/I+D | 01/04/2022 | - |
Historial de carrera de Scott Jeffers
Antiguos cargos conocidos de Scott Jeffers.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formación de Scott Jeffers.
| Purdue University | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Francia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Jeffers
- Experiencia
